Skip to content

Analysis of non-obstructive azoospermia and its clinical application based on single-cell transcriptome sequencing

Analysis of non-obstructive azoospermia and its clinical application based on single-cell transcriptome sequencing

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050188
Enrollment
Unknown
Registered
2021-08-21
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Azoospermia

Interventions

Gold Standard:Microscopic Sperm Surgery to Obtain Sperm
on&#32
the&#32
results&#32
from&#32
a&#32
model&#32
for&#32
of&#32
refined&#32

Sponsors

Shandong University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 58 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of NOA: According to the "Human Semen Examination and Sperm-Cervical Mucus Interaction Laboratory Manual", no less than 3 routine semen examinations indicate that no sperm can be found after centrifugation and microscopy. At the same time, follow European Urology As required by the Associations Male Infertility Guidelines, NOAs diagnosis is based on standard clinical examination procedures, including medical history, physical examination, routine semen analysis, seminal plasma biochemical examination, serum reproductive hormone analysis, ultrasound evaluation, chromosome karyotype analysis and Y chromosome analysis Microdeletion detection, etc.; 2. All NOA subjects did not receive conventional medical treatment; 3. Agreed to undergo microscopic sperm extraction, and there were no related surgical contraindications; 4. Healthy control group age-matched with NOA, healthy The clinical evaluation and semen parameters of the male reproductive system in the control group were all within the normal range.

Exclusion criteria

Exclusion criteria: 1. Patients with obstructive azoospermia; 2. Patients with hypogonadotropic syndrome; 3. Patients with chromosomal abnormalities; 4. Patients with AZFa region or AZFb region deletion; 5. Cryptorchidism Patients with secondary azoospermia caused by viral orchitis, varicocele, pituitary diseases, and systemic diseases.

Design outcomes

Primary

MeasureTime frame
Sperm retrieval rate;Testosterone;Follicle stimulating hormone;

Countries

China

Contacts

Public ContactGuo Li

Shandong University

glq_66@sdu.edu.cn+86 18253132651

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026